news Preclinical study highlights an effective combination immunotherapy for liver cancer 20 May 2022 | By Ria Kakkad (Drug Target Review) Study in mice significantly slowed liver tumour growth and activated anti-tumour immune response, highlighting an effective immunotherapy for liver cancer.
news Altering the body’s immune system to treat type 1 diabetes 17 May 2022 | By Ria Kakkad (Drug Target Review) Scientists have developed a novel type 1 diabetes treatment that involves transplanting pancreas cells that produce insulin.
news CRISPR used to treat Duchenne muscular dystrophy in mice 18 September 2019 | By Victoria Rees (Drug Target Review) A study has shown that CRISPR can be used as a regenerative technique to treat Duchenne muscular dystrophy, which could be developed as a therapeutic option for humans.